Home » Topics » BioWorld Science

BioWorld Science
RSS

New glucose-lowering compounds presented by Daiichi Sankyo

Aug. 2, 2019

Aurigene Discovery Technologies describes new anticancer agents

Aug. 2, 2019

Integral BioSciences discloses new TGFR-1 and MAPK14 inhibitors

Aug. 2, 2019

Momenta Pharmaceuticals launches phase II/III study of nipocalimab in wAIHA

Aug. 2, 2019

Lifesci Pharmaceuticals divulges KLKB1 inhibitors

Aug. 2, 2019

Zeno Royalties & Milestones patents Bcl-2 inhibitors

Aug. 2, 2019

Promedior presents phase II data on PRM-151 in patients with IPF

Aug. 2, 2019

Phase I study of PN-943 demonstrates sustained dose-related target engagement activity

Aug. 2, 2019

Rewind Therapeutics to discover drugs for myelin-related neurological diseases

Aug. 2, 2019

JMJD6 as a novel therapeutic target in neuroblastoma

Aug. 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...